ALPROLIX
ALPROLIX
Approved
DIN Number
02422913
Drug Class
Human
Market Date
Dec 11, 2015
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02422913
AIG Number0155510002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02BD04 COAGULATION FACTOR IX
Product Specifications
Dosage FormKit
,
Powder For Solution
Route of AdministrationIntravenous
AHFS Classification20:28.16
Health Canada Classification
ACTIVE INGREDIENTS (1)
RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEINActive
Strength: 500 UNIT / VIAL
Monograph: RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN